San Francisco, California–(Newsfile Corp. – July 18, 2025) – When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for…Read More

You might also be interested in reading Midland States Bancorp receives notification of deficiency from Nasdaq.